Netmarble’s head of corporate strategy and senior vice-president, Chanseok Choi, has been promoted to managing director and head of investment.
The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.
Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.
6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.
A leading company in the e-signature and digital transaction management space, San Francisco-based DocuSign went public in April last year, with a market capitalization of $4.4bn.
Maoyan is floating in Hong Kong at the bottom of its range, in an offering that will provide exits to Enlight, Tencent and Meituan Dianping.